• Home
  • >
  • Syncom Formulations India Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/syncom-formulations-india-ltd.png Logo

Syncom Formulations India Ltd Financial Statement

Syncom Formulations India Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue76.1467.6966.39
Operating Expense64.4656.5756.3
Net Profit6.756.426.21
Net Profit Margin8.879.489.35
Earning Per Share0.090.090.08
EBIDTA11.6411.039.65
Effective Tax Rate20.7218.7114.65

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Syncom Formulations India Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2017
Total Revenue Annual224.25219.66184.82
Operating Expenses Annual204.62199.63168.32
Operating Profit Annual34.2432.0519.28
Interest Annual3.131.930.28
Depreciation4.543.953.12
Net Profit Annual20.0719.7910.53
Tax Annual6.56.395.34

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Syncom Formulations India Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2017
Cash Flow at the Beginning0.32.755.69
Cash Flow from Operations10.5316.3313.84
Cash Flow from Investing-44.95-27.07-17.68
Cash Flow from Financing358.294.67
Cash Flow at the End0.880.36.52

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Syncom Formulations India Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2017
PBDIT Margin (%)15.3914.5910.46
PBIT Margin (%)13.3612.798.77
PBT Margin (%)9.446.16-17.79
Net PROFIT Margin (%)8.939.015.76
Return On Networth / Equity (%)8.398.919.32
Return On Networth /Employed(%)9.579.9313.22
Return On Assets (%)6.437.038.7
Total Debt / Equity(X)0.290.290.08
Asset Turnover Ratio (%)0.720.781.51

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Syncom Formulations India Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2017
Fixed Assets Annual43.446.6155.04
Total Current Assets Annual181.69139.882.79
Non Current Assets Annual196.14168.4497.38
Total Shareholders Funds Annual256.01222.22117.35
Total Assets Annual377.83308.24180.17

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Syncom Formulations India Ltd Earning Calls
Mar 2024
EPS beaten by 25.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Syncom Formulations India Ltd has a market capitalization of 1,050.92 Cr. Value Research classifies it as a Small-Cap company.

Yes, Syncom Formulations India Ltd is debt-free with a debt-to-equity ratio of 0.25.

In FY 2023, Syncom Formulations India Ltd recorded a total revenue of approximately 263.39 Cr marking a significant milestone in the company's financial performance.

Syncom Formulations India Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and 0.1% annually, respectively..

Syncom Formulations India Ltd's current PE ratio is 41.52.

Syncom Formulations India Ltd's ROCE averaged 9.8% from the FY ending March 2022 to 2024, with a median of 10.0%. It peaked at 10.6% in March 2024, reflecting strong capital efficiency over the period..

Syncom Formulations India Ltd's latest EBIT is Rs. 38.42 Cr, surpassing the average EBIT of Rs. 32.08 Cr over the 5 years..